Efficacy and safety of glucagon-like peptide-1 receptor agonists in the treatment of polycystic ovary syndrome-A systematic review and meta-analysis

被引:0
|
作者
Tong, Xin [1 ]
Song, Xiaoxuan [1 ]
Zhang, Yingshi [1 ]
Zhao, Qingchun [2 ]
机构
[1] Shenyang Pharmaceut Univ, 103 Wenhua Rd, Shenyang 110016, Peoples R China
[2] Shenyang Pharmaceut Univ, Gen Hosp Northern Theater Command, Teaching Hosp, 103 Wenhua Rd, Shenyang 110016, Peoples R China
关键词
Glucagon-like peptide 1 receptor agonists; polycystic ovary syndrome; obese; insulin resistance; hyperandrogenism; SIGNIFICANT WEIGHT-LOSS; OBESE WOMEN; EXENATIDE; LIRAGLUTIDE; METFORMIN; OVERWEIGHT; DIAGNOSIS; HEALTH; LEADS; PCOS;
D O I
10.1080/13813455.2024.2380422
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ContextPolycystic ovary syndrome (PCOS) is an endocrine gynaecological disorder that affects many women of childbearing age.ObjectiveTo evaluate the efficacy and safety of glucose-like peptide-1 receptor agonists for obese women with PCOS.MethodsWe searched the PubMed, Embase, WOS, and Cochrane Libarary databases up to June 2023. Studies were eligible if they were randomised controlled trials (RCTs) comparing GLP-1RAs against any other treatments for patients with PCOS.ResultsOverall, a total of 8 RCTs were included in this review, 7 of the RCTs compared GLP-1RAs with metformin, and 1 RCT compared GLP-1Ras with dapagliflozin. Compared with control group, GLP-1RAs were more effective at improving insulin sensitivity, reducing BMI, and resulting in a smaller waist circumference.ConclusionsGLP-1RAs may be a good option for obese women with PCOS, especially those with insulin resistance. However, high-quality studies are also needed in the future to assess the efficacy of GLP-1RAs in women with PCOS.
引用
收藏
页码:1005 / 1011
页数:7
相关论文
共 50 条
  • [1] Meta-Analysis of the Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Patients With Polycystic Ovary Syndrome
    Li, Lei
    Wang, Shu-Fang
    Du, Meng-Ru
    Jiang, Sheng
    AMERICAN JOURNAL OF THERAPEUTICS, 2022, 29 (02) : E245 - E248
  • [2] The therapeutic effects of glucagon-like peptide-1 receptor agonists and metformin on polycystic ovary syndrome A protocol for systematic review and meta-analysis
    Ma, Ruilin
    Ding, Xuesong
    Wang, Yanfang
    Deng, Yan
    Sun, Aijun
    MEDICINE, 2021, 100 (23) : E26295
  • [3] A Review and Meta-Analysis of the Safety and Efficacy of Using Glucagon-like Peptide-1 Receptor Agonists
    Hu, En-Hao
    Tsai, Ming-Lung
    Lin, Yuan
    Chou, Tien-Shin
    Chen, Tien-Hsing
    MEDICINA-LITHUANIA, 2024, 60 (03):
  • [4] Efficacy of glucagon-like peptide-1 receptor agonists for psoriasis: An updated systematic review and meta-analysis
    Ku, Su-Chi
    Chang, Hua-Ching
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2024, 22 (08): : 1148 - 1152
  • [5] Safety and efficacy of glucagon-like peptide-1 receptor agonists among kidney transplant recipients: a systematic review and meta-analysis
    Krisanapan, Pajaree
    Suppadungsuk, Supawadee
    Sanpawithayakul, Kanokporn
    Thongprayoon, Charat
    Pattharanitima, Pattharawin
    Tangpanithandee, Supawit
    Mao, Michael A.
    Miao, Jing
    Cheungpasitporn, Wisit
    CLINICAL KIDNEY JOURNAL, 2024, 17 (02)
  • [6] Efficacy and safety of glucagon-like peptide-1 receptor agonists on prediabetes: a systematic review and meta-analysis of randomized controlled trials
    Salamah, Hazem Mohamed
    Marey, Ahmed
    Abugdida, Mohamed
    Abualkhair, Khaled Alsayed
    Elshenawy, Salem
    Elhassan, Wael Atif Fadl
    Naguib, Mostafa Mahmoud
    Malnev, Dmitrii
    Durrani, Jamrose
    Bailey, Ronelle
    Tsyunchyk, Anastasiia
    Ibrahim, Lena
    Zavgorodneva, Zhanna
    Sherazi, Andleeb
    DIABETOLOGY & METABOLIC SYNDROME, 2024, 16 (01):
  • [7] Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Metabolic Associated Fatty Liver Disease A Systematic Review and Meta-analysis
    Jianping, Wu
    Xuelian, Zheng
    Anjiang, Wang
    Haiying, Xiao
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2021, 55 (07) : 586 - 593
  • [8] Safety and Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity: A Meta-Analysis
    Ryan, Paul M.
    Seltzer, Sean
    Hayward, Nathaniel E.
    Rodriguez, David Avelar
    Sless, Ryan T.
    Hawkes, Colin P.
    JOURNAL OF PEDIATRICS, 2021, 236 : 137 - 147
  • [9] Glucose Lowering Efficacy of Glucagon-Like Peptide-1 Receptor Agonists: A Meta-Analysis
    Vilsboll, Tina
    Christensen, Mikkel
    Knop, Filip K.
    Gluud, Lise L.
    DIABETES, 2011, 60 : A295 - A295
  • [10] Sex Differences in the Efficacy of Glucagon-Like Peptide-1 Receptor Agonists for Weight Reduction: A Systematic Review and Meta-Analysis
    Yang, Yucheng
    He, Liyun
    Han, Shumeng
    Yang, Na
    Liu, Yiwen
    Wang, Xuechen
    Li, Ziyi
    Ping, Fan
    Xu, Lingling
    Li, Wei
    Zhang, Huabing
    Li, Yuxiu
    JOURNAL OF DIABETES, 2025, 17 (03)